STOCK TITAN
  1. Home
  2. Sec-filings
  3. MOVE
  4. [Form 4] Corvex, Inc. Insider Trading Activity

Corvex, Inc. (MOVE) director exercises stock options, boosting holdings to 61,276 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Corvex, Inc. director Brian Cullinan exercised stock options to acquire 48,209 shares of Common Stock at an exercise price of $0.92 per share. These newly acquired shares increased his direct Common Stock holdings to 61,276 shares following the transaction. The exercised options, covering 48,209 shares, were fully converted into Common Stock and now have a reported post-transaction balance of zero. The filing notes that both the number of shares and the option exercise price were adjusted to reflect a prior stock dividend, where each share of Common Stock was automatically converted into 1.358 shares and distributed in early April 2026.

Positive

  • None.

Negative

  • None.

Insights

Routine option exercise increases director’s direct share ownership.

Director Brian Cullinan exercised stock options for 48,209 shares of Corvex, Inc. Common Stock at an exercise price of $0.92 per share. This is coded as a derivative exercise, not an open-market purchase or sale, and therefore carries weaker sentiment than discretionary trading.

After the exercise, his direct Common Stock holdings rise to 61,276 shares, while the exercised option position goes to zero, indicating a full conversion of that specific grant. Footnotes explain that both the share count and exercise price were adjusted by a prior stock dividend at a 1.358-to-1 ratio, so the figures are already post-adjustment.

Overall, this looks like a standard compensation-related event rather than a thesis-changing trade, with no sales or tax-withholding dispositions reported and no remaining derivatives listed in this filing’s derivative summary.

Insider Cullinan Brian
Role null
Type Security Shares Price Value
Exercise Stock Options (Right to Buy) 48,209 $0.00 --
Exercise Common Stock 48,209 $0.92 $44K
Holdings After Transaction: Stock Options (Right to Buy) — 0 shares (Direct, null); Common Stock — 61,276 shares (Direct, null)
Footnotes (1)
  1. As a result of the Company's stock dividend, each share of Common Stock issued and outstanding at the close of business on March 30, 2026 was automatically converted into 1.358 shares of Common Stock and was distributed on approximately April 6, 2026. The amounts reported on this Form 4 reflect the impacts of such stock dividend. This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. The number of subject shares and the exercise price of such option award has been adjusted by the stock dividend.
Options exercised 48,209 shares Common Stock acquired via option exercise on June 30, 2026
Exercise price $0.92 per share Adjusted option exercise price for Common Stock
Shares held after 61,276 shares Total direct Common Stock holdings post-transaction
Exercised option balance 0 shares remaining Stock Options balance following the exercise
Stock dividend ratio 1.358 shares per share Each Common share converted into 1.358 shares on March 30, 2026
Exercise transactions 2 coded M entries One non-derivative and one derivative record, both exercises
stock dividend financial
"As a result of the Company's stock dividend, each share of Common Stock issued and outstanding..."
A stock dividend is when a company gives its existing shareholders extra shares instead of cash. It’s like receiving more pieces of the same pie rather than a bigger piece of money, which can increase the number of shares you own but usually doesn’t change the total value of your investment right away. Investors care about it because it can signal the company's growth and affect the stock’s price.
Omnibus Incentive Plan financial
"an amendment to the Omnibus Incentive Plan that increases the number of shares..."
An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.
Plan Amendment financial
"shareholder approval of the Plan Amendment on December 16, 2025."
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
Common Stock financial
"each share of Common Stock issued and outstanding at the close of business..."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cullinan Brian
(Last)(First)(Middle)
C/O CORVEX, INC.
3401 NORTH FAIRFAX DRIVE, SUITE 3230
(Street)
ARLINGTON VIRGINIA 22226
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Corvex, Inc. [ MOVE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026M48,209A$0.9261,276(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy)$0.9206/30/2026M48,209 (2)06/30/2026Common Stock48,209$0.000D
Explanation of Responses:
1. As a result of the Company's stock dividend, each share of Common Stock issued and outstanding at the close of business on March 30, 2026 was automatically converted into 1.358 shares of Common Stock and was distributed on approximately April 6, 2026. The amounts reported on this Form 4 reflect the impacts of such stock dividend.
2. This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. The number of subject shares and the exercise price of such option award has been adjusted by the stock dividend.
/s/ Brian Cullinan by Mark R. Busch, attorney-in-fact06/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Corvex, Inc. (MOVE) director Brian Cullinan report?

Brian Cullinan reported exercising stock options to acquire 48,209 shares of Corvex, Inc. Common Stock. The options were exercised at an adjusted price of $0.92 per share, converting the derivative position into directly held shares under standard equity compensation mechanics.

How many Corvex, Inc. (MOVE) shares does Brian Cullinan hold after this Form 4?

Following the option exercise, Brian Cullinan directly holds 61,276 shares of Corvex, Inc. Common Stock. This reflects the addition of 48,209 newly acquired shares, with the reported figures already adjusted for the company’s prior stock dividend.

Did Brian Cullinan sell any Corvex, Inc. (MOVE) shares in this Form 4 filing?

No, the Form 4 shows only an option exercise to acquire shares, with no reported sales. Both transaction records are coded as derivative exercises, and the transaction summary lists zero sell transactions and neutral net buy-sell direction.

What was the exercise price for the Corvex, Inc. (MOVE) stock options?

The stock options were exercised at an adjusted price of $0.92 per share. A footnote explains that both the number of subject shares and the exercise price were modified to reflect Corvex, Inc.’s prior stock dividend and related plan amendment approval.

How did Corvex, Inc.’s stock dividend affect Brian Cullinan’s Form 4 figures?

The Form 4 states that each Common Stock share outstanding on March 30, 2026 converted into 1.358 shares, distributed around April 6, 2026. The reported option share count and $0.92 exercise price are already adjusted to incorporate this stock dividend impact.

What happened to Brian Cullinan’s Corvex, Inc. options after this transaction?

The specific stock option grant for 48,209 shares was fully exercised and now shows zero shares remaining. The derivative transaction record lists a total shares following transaction balance of 0.0000, indicating complete conversion into Common Stock as of the reported date.